| 000 | 01140 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514061946.0 | ||
| 264 | 0 | _c20030430 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/keg113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKassimos, D G | |
| 245 | 0 | 0 |
_aAnti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cMar 2003 |
||
| 300 |
_a490 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aGaryfallos, A | |
| 700 | 1 | _aDelamere, J | |
| 700 | 1 | _aWhallett, A | |
| 700 | 1 | _aKitas, G D | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 42 _gno. 3 _gp. 490 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/keg113 _zAvailable from publisher's website |
| 999 |
_c12421900 _d12421900 |
||